Bridging Inpatient to Outpatient Schizophrenia Care: Solutions for Safer Transitions
NeuroFrontiersBridging Inpatient to Outpatient Schizophrenia Care: Solutions for Safer Transitions
Negative Symptoms in Schizophrenia: Identifying and Managing the Hidden Burden
On the Frontlines of SchizophreniaNegative Symptoms in Schizophrenia: Identifying and Managing the Hidden Burden
Advancing Schizophrenia Care: When and How to Use Novel Therapies in Complex Patients
NeuroFrontiersAdvancing Schizophrenia Care: When and How to Use Novel Therapies in Complex Patients
Using fMRI to Identify Early Alzheimer’s Disease Subgroups
NeuroFrontiersUsing fMRI to Identify Early Alzheimer’s Disease Subgroups
Evaluating AR1001: A Phase 3 Trial in Early Alzheimer’s Disease
NeuroFrontiersEvaluating AR1001: A Phase 3 Trial in Early Alzheimer’s Disease
Understanding Schizophrenia: The Role of Neurotransmission and Inflammation
NeuroFrontiersUnderstanding Schizophrenia: The Role of Neurotransmission and Inflammation
- advertisement
- 3 questions
- advertisement
New Trial Device Opens Blood-Brain Barrier to Treat Glioblastoma
Medical Industry FeatureNew Trial Device Opens Blood-Brain Barrier to Treat Glioblastoma
Reassessing the Full Clinical Picture of ADHD
Medical Industry FeatureReassessing the Full Clinical Picture of ADHD
MMN in Practice: A Rare Motor Neuropathy Often Misdiagnosed
Medical Industry FeatureMMN in Practice: A Rare Motor Neuropathy Often Misdiagnosed
Aligning Efficacy With Patient Goals: The Role of SCIg in CIDP Maintenance
Medical Industry FeatureAligning Efficacy With Patient Goals: The Role of SCIg in CIDP Maintenance
From IVIg to SCIg: Rethinking Long-Term CIDP Therapy
Medical Industry FeatureFrom IVIg to SCIg: Rethinking Long-Term CIDP Therapy
- 12/05/2025
- 12/05/2025
- 12/05/2025
- 12/03/2025
- 12/03/2025
- 12/03/2025